damaged and unusable assets of Baht 2.30 million but there were cash paid for tools and equipment replacement after their useful life of Baht 15.21 million. The Corporate Group’s net cash used in financing

Description Unit: Million Baht Year 2018 Year 2017 Cash Flows from (used in) Operating Activities 274.97 296.18 Cash Flows from (used in) Investing Activities (7.85) (5.28) Cash Flows from (used in) Financing

Description Unit: Million Baht Year 2018 Year 2017 Cash Flows from (used in) Operating Activities 362.65 575.61 Cash Flows from (used in) Investing Activities (29.09) (16.74) Cash Flows from (used in) Financing

) Investing Activities (73.41) (50.32) Cash Flows from (used in) Financing Activities (307.20) (622.28) Unrealized exchange gain (loss) of cash and cash equivalents (0.61) (2.90) Cash Increase (Decrease) – Net

: Million Baht Year 2020 Year 2019 Cash Flows from Operating Activities 291.08 254.19 Cash Flows from (used in) Investing Activities (85.32) 75.83 Cash Flows used in Financing Activities (193.72) (317.01

activities Baht 426.6 million, cash flow used in investing activities Baht 2,374.2 million and cash flow received from financing activities Baht 2,060.6 million, cash and cash equivalent items as of the ended

which came from additional investments in investments in associated companies and fixed assets. Net cash from financing activities was Baht 1,496.09 million mainly from increased short-term debt. As a

activities Baht 603.0 million, cash flow used in investing activities Baht 1,671.4 million and cash flow received from financing activities Baht 993.8 million, cash and cash equivalent as of the ended 31

financing activities Baht 14.1 million, cash and cash equivalent items as of the ended 30 June 2017 is Baht 425.2 million, decreased from the 2016 by Baht 275.6 million as summarized; 3- 1. Net cash received

of 3.8% p.a. for the first year. The proceeds from the issuance of the Debentures will be used to refinance our higher interest rate borrowings (note that the combined financing costs of ABP3, ABPR1